Donald Long (Class of 2019) was awarded a fellowship through the NSF GRFP program. Don is in the Praveen Sethupathy lab.
His research focuses on tumor metabolism in Fibrolamellar Carcinoma (FLC), a rare form of liver cancer that is highly metastatic with a low rate of detection. This disease results in devastating levels of mortality in individuals with a median age of 20; currently, there are no viable treatments. Specifically, Don is investigating the role of a novel protein transporter in promoting FLC tumor growth and also exploring how specific microRNAs may contribute to the regulation of glycolysis and FLC cell survival.